FDA and WHOSTP discuss increasing clinical trials access and lowering barriers to participation

FDA Oncology shared on X:

“FDA Oncology Center’s Paul Kluetz, Rick Pazdur, Donna Rivera attended the White House Office of Science & Technology Policy Clinical Trials Forum yesterday to meet with stakeholders to discuss increasing clinical trials access and lowering barriers to participation to improve health outcomes.”

Source: FDA Oncology/X
.